Thomas K. Equels
Overview
Thomas K. Equels received an average of $1M in total compensation, including $642K in salary, at Hemispherx Biopharma from 2010 to 2018.
2018Hemispherx BiopharmaCEO & President
2017Hemispherx BiopharmaCEO & President
2016Hemispherx BiopharmaCEO & President
2015Hemispherx BiopharmaCEO & President
2014Hemispherx BiopharmaCEO & President
2013Hemispherx BiopharmaCEO, President, General Counsel
2012Hemispherx BiopharmaGeneral Counsel and Chief Financial Officer
2011Hemispherx BiopharmaGeneral Counsel
2010Hemispherx BiopharmaGeneral Counsel
Source: SEC filings on August 20, 2019, August 3, 2018, July 18, 2017, June 27, 2016, August 10, 2015, October 10, 2014, and September 16, 2013.
Related executives
We found eight more executives who work or worked at Hemispherx Biopharma.
Peter Rodino
Hemispherx Biopharma
General Counsel
Adam Pascale
Hemispherx Biopharma
Chief Financial Officer
David Strayer
Hemispherx Biopharma
Chief Scientific Officer
William Carter
Hemispherx Biopharma
Chief Executive Officer
Charles Bernhardt
Hemispherx Biopharma
Chief Financial Officer
Robert Dickey
Hemispherx Biopharma
Sr. Vice President
Wayne Springate
Hemispherx Biopharma
Sr. V.P., Operations
Russel Lander
Hemispherx Biopharma